Protein Name |
Pfam ID |
Percentage of Identity (%) |
E value |
Tyrosine-protein kinase ABL2 (ABL2)
|
|
31.188 (63/202) |
1.84E-17 |
Tyrosine-protein kinase ABL1 (ABL)
|
|
29.817 (65/218) |
6.53E-17 |
Tyrosine-protein kinase BTK (ATK)
|
|
27.632 (63/228) |
1.49E-16 |
Tyrosine-protein kinase FRK (FRK)
|
|
25.403 (63/248) |
4.57E-16 |
Janus kinase 1 (JAK-1)
|
|
25.000 (60/240) |
1.03E-15 |
Janus kinase 2 (JAK-2)
|
|
28.856 (58/201) |
1.18E-15 |
Serine/threonine-protein kinase B-raf (BRAF)
|
|
27.830 (59/212) |
1.55E-15 |
Proto-oncogene c-Fes (FES)
|
|
26.364 (58/220) |
2.05E-15 |
Proto-oncogene c-RAF (c-RAF)
|
|
28.311 (62/219) |
2.10E-15 |
Ephrin type-B receptor 1 (EPHB1)
|
|
25.238 (53/210) |
3.53E-15 |
Mixed lineage kinase 3 (MAP3K11)
|
|
31.034 (63/203) |
8.52E-15 |
Tyrosine-protein kinase Srms (SRMS)
|
|
25.275 (92/364) |
9.03E-15 |
Proto-oncogene c-Src (SRC)
|
|
28.302 (60/212) |
9.27E-15 |
Muscle-specific kinase receptor (MUSK)
|
|
26.364 (58/220) |
1.03E-14 |
Mitogen-activated protein kinase kinase kinase 13 (MAP3K13)
|
|
25.381 (50/197) |
1.09E-14 |
Discoidin domain-containing receptor 2 (DDR2)
|
|
26.339 (59/224) |
1.56E-14 |
Titin (TTN)
|
23.129 (68/294) |
1.56E-14 |
LCK tyrosine protein kinase (LCK)
|
|
26.941 (59/219) |
1.86E-14 |
Yes tyrosine kinase (YES)
|
|
27.354 (61/223) |
2.32E-14 |
Fibroblast growth factor receptor 1 (FGFR1)
|
|
29.237 (69/236) |
2.52E-14 |
Fyn tyrosine protein kinase (FYN)
|
|
27.556 (62/225) |
2.81E-14 |
Tyrosine-protein kinase Lyn (JTK8)
|
|
27.143 (57/210) |
3.36E-14 |
Mixed lineage kinase 2 (MAP3K10)
|
|
32.020 (65/203) |
3.36E-14 |
B lymphocyte kinase (BLK)
|
|
29.018 (65/224) |
4.59E-14 |
Serine/threonine-protein kinase A-Raf (ARAF)
|
|
26.852 (58/216) |
5.54E-14 |
Fibroblast growth factor receptor 2 (FGFR2)
|
|
27.660 (65/235) |
5.74E-14 |
Neurotrophic tyrosine kinase ROR1 (ROR1)
|
|
23.571 (66/280) |
6.21E-14 |
TYK2 tyrosine kinase (TYK2)
|
|
26.733 (54/202) |
8.62E-14 |
Ephrin type-A receptor 3 (EPHA3)
|
|
27.778 (60/216) |
1.06E-13 |
Ephrin type-B receptor 4 (EPHB4)
|
|
26.214 (54/206) |
1.69E-13 |
Testis-specific kinase 2 (TESK2)
|
|
30.769 (60/195) |
1.73E-13 |
Ephrin type-A receptor 2 (EPHA2)
|
|
23.980 (47/196) |
1.87E-13 |
Mitogen-activated protein kinase kinase kinase 12 (MAP3K12)
|
|
25.888 (51/197) |
1.92E-13 |
Proto-oncogene c-Fer (FER)
|
|
25.500 (51/200) |
2.62E-13 |
Tyrosine-protein kinase Tec (PSCTK4)
|
|
27.854 (61/219) |
2.67E-13 |
Janus kinase 3 (JAK-3)
|
|
28.000 (56/200) |
5.08E-13 |
T-cell-specific kinase (ITK)
|
|
26.484 (58/219) |
5.71E-13 |
Tyrosine-protein kinase BRK (PTK6)
|
|
27.103 (58/214) |
5.85E-13 |
MLK-related kinase (MLTK)
|
|
26.484 (58/219) |
6.71E-13 |
Megakaryocyte-associated tyrosine-protein kinase (MATK)
|
|
26.601 (54/203) |
7.76E-13 |
TGF-beta-activated kinase 1 (MAP3K7)
|
|
30.653 (61/199) |
7.98E-13 |
Ephrin type-B receptor 3 (EPHB3)
|
|
26.471 (54/204) |
1.03E-12 |
Renal carcinoma antigen NY-REN-64 (IRAK-4)
|
|
29.064 (59/203) |
1.04E-12 |
Hematopoietic cell kinase (HCK)
|
|
24.911 (70/281) |
1.06E-12 |
LIM domain kinase-2 (LIMK-2)
|
|
27.053 (56/207) |
1.27E-12 |
LIM domain kinase-1 (LIMK-1)
|
|
29.078 (41/141) |
1.70E-12 |
Activated CDC42 kinase 1 (ACK-1)
|
|
28.713 (58/202) |
2.34E-12 |
Ephrin type-A receptor 5 (EPHA5)
|
|
24.103 (47/195) |
2.71E-12 |
Testis-specific kinase 1 (TESK1)
|
|
25.455 (56/220) |
4.98E-12 |
Mixed lineage kinase 4 (MAP3K21)
|
|
28.261 (65/230) |
5.04E-12 |
Tyrosine-protein kinase Fgr (FGR)
|
|
26.887 (57/212) |
5.25E-12 |
Ephrin type-A receptor 7 (EPHA7)
|
|
25.701 (55/214) |
5.82E-12 |
Neurotrophic tyrosine kinase ROR2 (ROR2)
|
|
24.291 (60/247) |
6.97E-12 |
Focal adhesion kinase 2 (PTK2B)
|
|
24.876 (50/201) |
1.10E-11 |
BDNF/NT-3 growth factors receptor (TrkB)
|
|
27.619 (58/210) |
1.28E-11 |
Serine/threonine-protein kinase TNNI3K (TNNI3K)
|
|
26.108 (53/203) |
1.62E-11 |
Fibroblast growth factor receptor 3 (FGFR3)
|
|
25.424 (60/236) |
1.65E-11 |
Tropomyosin-related kinase A (TrkA)
|
|
26.540 (56/211) |
2.23E-11 |
Ephrin type-A receptor 1 (EPHA1)
|
|
23.737 (47/198) |
2.43E-11 |
Receptor-interacting protein 1 (RIPK1)
|
|
26.250 (42/160) |
3.36E-11 |
Proto-oncogene c-Met (MET)
|
|
26.087 (54/207) |
3.47E-11 |
Tyrosine-protein kinase CSK (CSK)
|
|
27.000 (54/200) |
4.19E-11 |
Inactive tyrosine-protein kinase 7 (PTK7)
|
|
23.673 (58/245) |
4.40E-11 |
Ephrin type-A receptor 4 (EPHA4)
|
|
23.077 (48/208) |
5.11E-11 |
Proto-oncogene c-Ret (RET)
|
|
26.087 (60/230) |
6.14E-11 |
Vascular endothelial growth factor receptor 3 (FLT-4)
|
|
29.661 (35/118) |
9.44E-11 |
Ephrin type-B receptor 2 (EPHB2)
|
|
23.810 (50/210) |
1.19E-10 |
Fibroblast growth factor receptor 4 (FGFR4)
|
|
24.675 (57/231) |
1.30E-10 |
Vascular endothelial growth factor receptor 1 (FLT-1)
|
|
30.282 (43/142) |
1.43E-10 |
Focal adhesion kinase 1 (FAK)
|
|
23.560 (45/191) |
2.11E-10 |
Tyrosine-protein kinase ZAP-70 (ZAP-70)
|
|
25.424 (60/236) |
2.17E-10 |
Non-receptor tyrosine-protein kinase TNK1 (TNK1)
|
|
29.208 (59/202) |
3.35E-10 |
Ephrin type-A receptor 8 (EPHA8)
|
|
24.742 (48/194) |
6.54E-10 |
Vascular endothelial growth factor receptor 2 (KDR)
|
|
26.891 (32/119) |
9.36E-10 |
Tyrosine-protein kinase TXK (TXK)
|
|
23.590 (46/195) |
1.06E-09 |
Angiopoietin 1 receptor (TEK)
|
|
25.664 (58/226) |
1.18E-09 |
Epidermal growth factor receptor (EGFR)
|
|
24.020 (49/204) |
1.63E-09 |
Epithelial discoidin domain receptor 1 (DDR1)
|
|
25.000 (47/188) |
1.99E-09 |
NT-3 growth factor receptor (TrkC)
|
|
24.348 (56/230) |
2.43E-09 |
Tyrosine-protein kinase RYK (RYK)
|
|
22.407 (54/241) |
3.70E-09 |
Insulin-like growth factor I receptor (IGF1R)
|
|
24.638 (51/207) |
4.81E-09 |
Tyrosine-protein kinase BMX (BMX)
|
|
25.373 (51/201) |
6.81E-09 |
Tyrosine-protein kinase SYK (SYK)
|
|
23.834 (46/193) |
8.51E-09 |
Macrophage-stimulating protein receptor (RON)
|
|
25.123 (51/203) |
9.07E-09 |
Tyrosine-protein kinase Mer (MERTK)
|
|
23.982 (53/221) |
1.22E-08 |
Tyrosine-protein kinase UFO (AXL)
|
|
24.627 (66/268) |
2.44E-08 |
Tie-1 tyrosine kinase receptor (TIE1)
|
|
25.000 (56/224) |
2.96E-08 |
Platelet-derived growth factor receptor alpha (PDGFRA)
|
|
27.407 (37/135) |
4.18E-08 |
Insulin receptor (INSR)
|
|
23.346 (60/257) |
4.31E-08 |
Fms-like tyrosine kinase 3 (FLT-3)
|
|
26.400 (33/125) |
5.53E-08 |
Insulin receptor-related protein (INSRR)
|
|
23.853 (52/218) |
1.19E-07 |
Serine/threonine-protein kinase LMTK1 (AATK)
|
|
26.490 (40/151) |
1.47E-07 |
TGF-beta receptor type II (TGFBR2)
|
|
27.273 (60/220) |
1.56E-07 |
Tyrosine-protein kinase Kit (KIT)
|
|
28.800 (36/125) |
1.86E-07 |
Erbb4 tyrosine kinase receptor (Erbb-4)
|
|
24.365 (48/197) |
1.95E-07 |
Activin receptor-like kinase 2 (ALK-2)
|
|
28.372 (61/215) |
3.17E-07 |
Kinase suppressor of Ras 2 (KSR2)
|
|
24.675 (38/154) |
3.82E-07 |
Erbb2 tyrosine kinase receptor (HER2)
|
|
25.248 (51/202) |
4.35E-07 |
Ephrin type-A receptor 6 (EPHA6)
|
|
23.140 (56/242) |
5.46E-07 |
Platelet-derived growth factor receptor beta (PDGFRB)
|
|
27.500 (33/120) |
8.75E-07 |
Erbb3 tyrosine kinase receptor (Erbb-3)
|
|
26.368 (53/201) |
9.38E-07 |
Kinase suppressor of Ras-1 (KSR1)
|
|
20.779 (48/231) |
1.54E-06 |
Ankyrin repeat and protein kinase domain-containing protein 1 (ANKK1)
|
|
21.771 (59/271) |
2.60E-06 |
Serine/threonine-protein kinase LMTK3 (LMTK3)
|
|
23.684 (54/228) |
4.51E-06 |
Tyrosine-protein kinase STYK1 (STYK1)
|
|
27.215 (43/158) |
5.92E-06 |
Dual serine/threonine and tyrosine protein kinase (DSTYK)
|
|
22.660 (46/203) |
8.70E-06 |
Mixed lineage kinase domain-like protein (MLKL)
|
|
23.182 (51/220) |
1.30E-05 |
Retinal guanylyl cyclase 2 (GUCY2F)
|
|
26.733 (27/101) |
1.57E-05 |
Macrophage colony-stimulating factor 1 receptor (CSF1R)
|
|
25.352 (36/142) |
2.45E-05 |
Bone morphogenetic protein receptor type-1B (BMPR1B)
|
|
26.638 (61/229) |
4.20E-05 |
TYRO3 tyrosine kinase receptor (TYRO3)
|
|
30.097 (31/103) |
7.18E-05 |
Soluble guanylyl cyclase (GUCY2D)
|
|
28.440 (31/109) |
1.40E-04 |
Activin receptor type-1C (ACVR1C)
|
|
25.217 (58/230) |
1.66E-04 |
Serine/threonine-protein kinase LMTK2 (LMTK2)
|
|
23.585 (50/212) |
2.31E-04 |
Bone morphogenetic protein receptor type-1A (BMPR1A)
|
|
27.434 (62/226) |
3.23E-04 |
Atrial natriuretic peptide receptor B (NPR2)
|
|
25.703 (64/249) |
1.00E-03 |
Receptor-interacting serine/threonine-protein kinase 2 (RIPK2)
|
|
22.707 (52/229) |
1.00E-03 |
Click to Show/Hide the Information of Human Similarity Proteins |